Emerging Trend of Multidrug-resistant Organisms Causing Sepsis in Ventilated Newborns

Sudesh Kumar1, Prajna Ray, Ranita Sahana

  • 1Department of Paediatrics, MGM Medical College, Kishanganj, Bihar, India.

PubMed

Insights

Multidrug-resistant organisms are a significant threat in neonatal intensive care units. This study found a high prevalence of these resistant bacteria, particularly Gram-negative strains, in ventilated newborns with sepsis.

Area of Science:

  • Neonatalogy
  • Infectious Diseases
  • Microbiology

Background:

  • Antibiotic and multidrug resistance (MDR) pose significant public health risks.
  • MDR organisms are a major concern in intensive care units (ICUs).
  • Ventilated newborns in the NICU are particularly vulnerable to infections.

Purpose of the Study:

  • To identify and determine the prevalence of MDR organisms in sepsis-positive ventilated newborns.
  • To evaluate the antibiotic resistance patterns of these isolated MDR organisms.
  • To assess the impact of MDR on neonatal sepsis outcomes.

Main Methods:

  • An observational cross-sectional study was conducted in a neonatal ICU.
  • 168 neonates were enrolled, with data collected on culture positivity and organism identification.
  • Antibiotic resistance patterns were analyzed for isolated MDR strains.

Main Results:

  • Culture positivity was observed in 79 (47.02%) of 168 ventilated neonates.
  • 53 (67.08%) of isolated organisms were MDR, with Gram-negative strains being more prevalent (56.6%).
  • Pseudomonas aeruginosa and coagulase-negative staphylococci (CONS) were the most common MDR organisms. High resistance rates were noted against common antibiotics.

Conclusions:

  • There is an alarmingly high prevalence of MDR organisms, especially Gram-negative strains, in EONS.
  • The presence of MDR limits initial antibiotic choices, potentially increasing mortality and morbidity.
  • Effective strategies are needed to combat the spread of resistant organisms in neonatal ICUs.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
458
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
458
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
388
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
622